https://scholars.lib.ntu.edu.tw/handle/123456789/417356
標題: | Pretreatment serum lactate level as a prognostic biomarker in patients undergoing supratentorial primary brain tumor resection | 作者: | CHUNG-CHIH SHIH TZONG-SHIUN LEE FON-YIH TSUANG PEI-LIN LIN YA-JUNG CHENG HSIAO-LIANG CHENG CHUN-YU WU |
關鍵字: | brain tumor; glioma; lactate; prognostic factor; tumor marker;Brain tumor; Glioma; Lactate; Prognostic factor; Tumor marker | 公開日期: | 8-九月-2017 | 出版社: | IMPACT JOURNALS LLC | 卷: | 8 | 期: | 38 | 起(迄)頁: | 63715 | 來源出版物: | Oncotarget | 摘要: | Malignant primary brain tumors are one of the most aggressive cancers. Pretreatment serum nonneuronal biomarkers closely associated with postoperative outcomes are of high clinical relevance. The present study aimed to identify potential pretreatment serum biomarkers that may influence oncological outcomes in patients with primary brain tumors. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85029800108&doi=10.18632%2foncotarget.18891&partnerID=40&md5=9316c00227bdd060210fc665171893ff https://scholars.lib.ntu.edu.tw/handle/123456789/417356 |
ISSN: | 1949-2553 | DOI: | 10.18632/oncotarget.18891 | SDG/關鍵字: | glial fibrillary acidic protein; lactate dehydrogenase; lactic acid; neuron specific enolase; neutrophil gelatinase associated lipocalin; protein S100B; tumor marker; adult; Article; brain surgery; brain tumor; cancer grading; cancer prognosis; cancer surgery; cancer survival; cohort analysis; controlled study; diagnostic test accuracy study; female; human; lactate blood level; major clinical study; male; overall survival; progression free survival; receiver operating characteristic; survival analysis |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。